Summary : AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein…
Tag:
disease
-
-
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5…
-
Summary : BDR Pharma, the Mumbai-based drugmaker that raised around ₹750 crore earlier this year…
-
Summary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based…
-
Global MarketPharma Science & Research
Scancell gains new facilities at The Oxford Science Park
by adminSummary : British biotech company Scancell has expanded its research and development capabilities at one…
-
Summary : Chicago-based AbbVie has been making major decisions with company-wide impacts. The therapeutic company…
-
ChemIntelligenceGsk
GSK’s Bad Week: Maternal RSV Vaccine Paused, Trade Secrets Violation Alleged
by adminSynopsis: GlaxoSmithKline has voluntarily paused activities in its Phase III GRACE trial on an experimental…
-
Summary : The DTAB has approved a list of OTC drugs which includes medicines like…
-
Summary : Vigabatrin is used to treat babies, one month to two years old with…
-
ChemIntelligencePharma Science & Research
Oxford joins Consortium to advance Quantum Drug Discovery
by adminSummary : -The partnership between Oxford University and SEEQC promises to accelerate the use of…
Newer Posts